The FDA Meeting of the Psychopharmacologic Drugs Advisory Committee evaluating the New Drug Application for MDMA is happening now. How do clinicians feel about this potential treatment for PTSD?
Rachel Dalthorp, MD, MHSA
Advertisement
Dr Dalthorp is the executive medical director of LifeStance Health and a reproductive psychiatrist at Balance Women’s Health. She is passionate about women's mental health, treatment resistant depression, and innovation in psychiatry.
Articles by Rachel Dalthorp, MD, MHSA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Increased Risk of Death in Patients With Dementia Found Related to Common Hospice Medications
2
Treating Mental Illness During Pregnancy the Same as Any Medical Illness: In Conversation With Jennifer L. Payne, MD
3
The Use of Aripiprazole for Bipolar Disorder
4
FDA Accepts NDA for CTx-1301 for Treatment of ADHD
5
